Traws Pharma, Inc. Fair Value, Assets, Level 2 to Level 1 Transfers, Amount
Traws Pharma, Inc. (TRAW) had Fair Value, Assets, Level 2 to Level 1 Transfers, Amount of $0 as of 2020-12-31, per its 10-K filed 2021-03-18.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount · last filed 2021-03-18
- 2020-12-31: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2020-09-30: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2020-06-30: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2020-03-31: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
| Period end | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-18 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-16 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-12 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-15 |
| 2019-12-31 | $0.00 10-K · filed 2020-03-27 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-12 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-14 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-15 |
| 2018-12-31 | $0.00 10-K · filed 2019-04-01 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-14 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-14 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-15 |
| 2017-12-31 | $0.00 10-K · filed 2018-03-16 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-09 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-14 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 |
| 2016-12-31 | $0.00 10-K · filed 2017-03-29 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-14 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-15 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-11 |
| 2014-12-31 | $0.00 10-K · filed 2015-03-30 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-14 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-14 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-15 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-30 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-14 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |